Search Options Stock News and Analysis from Schaeffer's

Signal Says Buy Options Insurance on This Biotech

https://www.schaeffersresearch.com/content/analysis/2019/03/18/signal-says-buy-options-insurance-on-this-biotech

3/18/2019 1:06 PM

Exelixis, Inc. (NASDAQ:EXEL) shares are fresh off a new high, thanks to some upbeat analyst attention. Specifically, Morgan Stanley upgraded the biotech stock to "equal weight" from "underweight," and...

Earnings Release Sparks Whipsaw Trading on Exelixis Stock

https://www.schaeffersresearch.com/content/news/2019/02/13/earnings-release-sparks-whipsaw-trading-on-exelixis-stock

2/13/2019 10:29 AM

The shares of Exelixis Inc. (NASDAQ:EXEL) shot higher out of the gate this morning, but were last seen down 0.7% at $21.53, even though the company reported fourth-quarter earnings and revenue that ...

Exelixis Stock Buried By Failed Cancer Drug Study

https://www.schaeffersresearch.com/content/news/2018/05/10/exelixis-stock-buried-by-failed-cancer-drug-study

5/10/2018 10:19 AM

Exelixis, Inc. (NASDAQ:EXEL) stock is down 11.8% to trade at $19.13 this morning, after the biotech company's colorectal cancer drug that was tested in combination with Roche's Tecentriq failed late-...

2 Biotech Stocks That Could Burst Higher

https://www.schaeffersresearch.com/content/analysis/2018/02/23/2-biotech-stocks-that-could-burst-higher

2/23/2018 1:18 PM

ImmunoGen, Inc. (NASDAQ:IMGN) shares have been on a tear in 2018, advancing more than 75% already this year. What's more, IMGN stock could have room to run, if recent history is any indicator. Meanwhi...

This Drug Stock is a Steal

https://www.schaeffersresearch.com/content/analysis/2018/01/19/this-drug-stock-is-a-steal

1/19/2018 2:48 PM

The shares of biotech Exelixis, Inc. (NASDAQ:EXEL) -- which makes Cabometyx -- have been in a channel of higher highs and lows since early 2016, gaining 55% over the past year. Since its most recent...

PEOPLE ALSO SEARCH FOR